Sam Gandy, MD, PhD, is Mount Sinai Professor of Alzheimer's Disease Research, Professor of Neurology and Psychiatry, Associate Director of the Mount Sinai Alzheimer's Disease Research Center in New York City, and Past Chairman of the National Medical and Scientific Advisory Council of the Alzheimer's Association. Gandy and his team discovered the first drugs that could activate a-secretase processing of APP and reduce generation of the amyloid b peptide. Dr. Gandy has written more than 300 original papers, chapters, and reviews on this and related topics. Dr. Gandy has received continuous NIH funding for his research on APP and Ab metabolism since 1986. Dr. Gandy received both his MD and PhD at the Medical University of South Carolina.

He completed an internship in internal medicine and a residency in neurology at what is now known at The New York-Presbyterian Medical Center. Dr. Gandy completed postdoctoral training at The Rockefeller University, in the laboratory of Paul Greengard, 2000 Laureate of the Nobel Prize in Physiology or Medicine.

From 1992-1997, Gandy was Associate Professor of Neurology and Neuroscience at Cornell University Medical College. From 1997-2001, he was Professor of Psychiatry and of Cell Biology at New York University and The Nathan S. Kline Institute for Psychiatric Research. From 2001-2007, he served as the Paul C. Brucker, M.D., Professor of Neuroscience at Jefferson Medical College, and Founding Director of the Farber Institute for Neurosciences. In 2007, he assumed his current post as Mount Sinai Professor of Alzheimer's Disease Research at the Icahn School of Medicine at Mount Sinai.